ArticleClinical ophthalmology (Auckland, N.Z.)2018
A retrospective analysis of the use of loteprednol etabonate ophthalmic suspension 0.5% following canaloplasty.
Mahmoud A KhaimiPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it